The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition

couple looking at beach cover
This publication focuses on therapies (such as bisphosphonates) given to patient with myeloma bone lesions, lytic lesions, or myeloma bone disease.
family walking in forest
This publication discusses the option of autologous stem cell transplant (ASCT) for the treatment of myeloma.
couple standing next to window
This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.
couple portrait shot
This publication discusses the use of Kyprolis (carfilzomib)— a proteasome inhibitor—for the treatment of myeloma.

Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will bring you up to speed on myeloma and its treatment. All IMF publications are available free-of-charge.

family photo
This publication discusses the use of Farydak (panobinostat)—a histone deactlylase (HDAC) inhibitor—for the treatment of myeloma

We Thank Our Sponsors:
Amgen, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen Karyopharm, Sanofi and Takeda Oncology

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.